Additive Intraocular Pressure Lowering Effects of Ripasudil in Patients with Primary Open Angle Glaucoma and Ocular Hypertension

• Huvudskapare: Asma Jabeen (Författare, medförfattare), Ashok K Sharma (Författare, medförfattare), Hans Raj Sharma (Författare, medförfattare)
• Materialtyp: Bok
• Publicerad: Dr. Annil Mahajan, 2024-01-01T00:00:00Z.
• Ämnen: article
• Länkar: Connect to this object online.

Introduction: Glaucoma is one of the leading causes of irreversible blindness worldwide. Among the affected ones, approximately 50% are not aware of it, because of its asymptomatic nature, especially in the early stages. Ripasudil Hydrochloride Hydrate is a novel drug, being the Rho-associated coile...